Monday, August 24, 2020 8:59:56 PM
PAOG worked a deal w PURA for a 1:1 dividend and RBII still provides PAOG shareholders w a % of revenues I think. At least they did before. What does that mean for shareholders I wonder? I know they are in different sectors but there still has been no update about how they are still related thru dividend/%. I thought pAogroup owns Pura now and somethin about 1:1 dividends maybe something happened w FDA fast track or NIH research project w the covid19 therapeutic. Wonder if Cannophen comes into play here. And plz do Not try to tell me that Cannophen has nothing to do w RBII anymore cuz RBII created Cannophen and CEO has stated in previous PRs that Cannophen is our flagship product. Also the barcode for Cannophen is still the very 1st post that is posted to Rising biosciences Facebook page. Maybe something is brewing. I know the pao group drug that's been set forth for covid19 Ctap and FDA approval NIH research is another drug but I wonder if Cannophen comes into play still
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM